Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1841 1
1843 1
1851 1
1872 1
1873 1
1875 2
1878 2
1881 2
1882 2
1883 1
1886 1
1887 1
1891 1
1892 1
1893 2
1894 1
1897 1
1898 1
1905 2
1908 2
1909 1
1910 5
1911 1
1912 1
1913 1
1914 2
1915 1
1918 1
1919 1
1921 2
1922 3
1923 2
1924 1
1925 3
1926 1
1927 3
1928 5
1929 1
1930 2
1931 2
1932 2
1933 4
1934 3
1935 2
1937 1
1939 6
1940 2
1941 1
1942 1
1943 3
1945 1
1946 9
1947 18
1948 10
1949 17
1950 15
1951 26
1952 14
1953 25
1954 17
1955 27
1956 19
1957 14
1958 23
1959 31
1960 37
1961 37
1962 31
1963 31
1964 41
1965 58
1966 57
1967 51
1968 47
1969 51
1970 65
1971 36
1972 55
1973 46
1974 41
1975 268
1976 278
1977 280
1978 282
1979 291
1980 317
1981 329
1982 357
1983 397
1984 496
1985 494
1986 504
1987 587
1988 547
1989 713
1990 755
1991 737
1992 823
1993 816
1994 839
1995 890
1996 918
1997 920
1998 954
1999 968
2000 1049
2001 999
2002 1084
2003 1145
2004 1159
2005 1201
2006 1413
2007 1443
2008 1508
2009 1525
2010 1673
2011 1817
2012 1865
2013 2050
2014 2147
2015 2026
2016 2081
2017 2106
2018 2181
2019 2419
2020 2708
2021 3048
2022 3023
2023 3006
2024 1246

Text availability

Article attribute

Article type

Publication date

Search Results

56,773 results

Results by year

Filters applied: . Clear all
Page 1
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.
Rueda OM, Sammut SJ, Seoane JA, Chin SF, Caswell-Jin JL, Callari M, Batra R, Pereira B, Bruna A, Ali HR, Provenzano E, Liu B, Parisien M, Gillett C, McKinney S, Green AR, Murphy L, Purushotham A, Ellis IO, Pharoah PD, Rueda C, Aparicio S, Caldas C, Curtis C. Rueda OM, et al. Nature. 2019 Mar;567(7748):399-404. doi: 10.1038/s41586-019-1007-8. Epub 2019 Mar 13. Nature. 2019. PMID: 30867590 Free PMC article.
Long-term follow-up is especially important for those with oestrogen-receptor (ER)-positive breast cancers, which can recur up to two decades after initial diagnosis(1-6). It is therefore essential to identify patients who have a high risk of late relapse(7-9). ...We also …
Long-term follow-up is especially important for those with oestrogen-receptor (ER)-positive breast cancers, which can recur up to two …
Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A, Javed AA, Michelakos T, Sekigami Y, Zheng J, Kalvin HL, McIntyre CA, Nebbia M, Chou JF, Gonen M, Raj N, Reidy-Lagunes DL, Zureikat AH, Ferrone CR, He J, Wei AC; PAncreatic Neuroendocrine Disease Alliance (PANDA). Pulvirenti A, et al. Ann Surg. 2023 Nov 1;278(5):e1063-e1067. doi: 10.1097/SLA.0000000000005809. Epub 2023 Jan 24. Ann Surg. 2023. PMID: 37796750
OBJECTIVE: The objective of this study was to describe the pattern of recurrence, treatments received, as well the oncological outcomes, of pancreatic neuroendocrine tumors (PanNETs) following curative surgery. BACKGROUND: PanNETs recur in 10% to 15% of cases following sur …
OBJECTIVE: The objective of this study was to describe the pattern of recurrence, treatments received, as well the oncological outcomes, of …
To respond or not to respond, the recurring question in plant mechanosensitivity.
Leblanc-Fournier N, Martin L, Lenne C, Decourteix M. Leblanc-Fournier N, et al. Front Plant Sci. 2014 Aug 14;5:401. doi: 10.3389/fpls.2014.00401. eCollection 2014. Front Plant Sci. 2014. PMID: 25177327 Free PMC article. Review.
In nature, terrestrial plants experience many kinds of external mechanical stimulation and respond by triggering a network of signaling events to acclimate their growth and development. Some environmental cues, especially wind, recur on time scales varying from seconds to …
In nature, terrestrial plants experience many kinds of external mechanical stimulation and respond by triggering a network of signaling even …
Recurring hydatide cyst in abdominal cavity. A case report.
Moreno-Galeana S, Mora-Muñoz VS, Marmolejo-Estrada J, Servín-Torres E. Moreno-Galeana S, et al. Cir Cir. 2021;89(S2):45-58. doi: 10.24875/CIRU.21000107. Cir Cir. 2021. PMID: 34932531 Free article. English.
It may be asymptomatic or present with compression discomfort or anaphylactic shock due to cyst rupture. The disease can recur. The diagnosis is made by the symptoms and imaging findings. ...
It may be asymptomatic or present with compression discomfort or anaphylactic shock due to cyst rupture. The disease can recur. The d …
Recurring chemotherapy-associated alopecia areata: case report and literature review.
Motl SE, Fausel C. Motl SE, et al. Pharmacotherapy. 2003 Jan;23(1):104-8. doi: 10.1592/phco.23.1.104.31918. Pharmacotherapy. 2003. PMID: 12523468 Review.
A 52-year-old woman with stage IIIC ovarian cancer and stage IA uterine cancer experienced recurring alopecia areata of her eyebrows, eyelashes, arms, legs, and pubic area beginning 5 months after completing chemotherapy with paclitaxel and carboplatin. The condition re
A 52-year-old woman with stage IIIC ovarian cancer and stage IA uterine cancer experienced recurring alopecia areata of her eyebrows, …
Repeatedly recurring pleomorphic adenoma: a therapeutic challenge.
Aro K, Valle J, Tarkkanen J, Mäkitie A, Atula T. Aro K, et al. Acta Otorhinolaryngol Ital. 2019 Jun;39(3):156-161. doi: 10.14639/0392-100X-2307. Acta Otorhinolaryngol Ital. 2019. PMID: 31131834 Free PMC article.
Pleomorphic adenoma (PA) is the most common tumour of the salivary glands, and can recur even after proper surgery. The extent and timing of surgery for recurrent tumours remains controversial, and multiple recurrences pose a special challenge. ...Patients with RPA are oft …
Pleomorphic adenoma (PA) is the most common tumour of the salivary glands, and can recur even after proper surgery. The extent and ti …
Recurring Weakness in Rhabdomyolysis Following Pfizer-BioNTech Coronavirus Disease 2019 mRNA Vaccination.
Kimura M, Niwa JI, Doyu M. Kimura M, et al. Vaccines (Basel). 2022 Jun 11;10(6):935. doi: 10.3390/vaccines10060935. Vaccines (Basel). 2022. PMID: 35746543 Free PMC article.
Rhabdomyolysis following coronavirus disease 2019 (COVID-19) vaccination has recently been reported. The patients' weakness gradually subsided and did not recur. Rhabdomyolysis associated with COVID-19 vaccination has not been assessed by repeated magnetic resonance imagin …
Rhabdomyolysis following coronavirus disease 2019 (COVID-19) vaccination has recently been reported. The patients' weakness gradually subsid …
Spinal osteoid osteoma recurring as an aggressive osteoblastoma.
López-Puerta JM, Fernández-Marín MR, Martín Benlloch JA, Lorente R. López-Puerta JM, et al. Neurocirugia (Astur : Engl Ed). 2020 May-Jun;31(3):146-150. doi: 10.1016/j.neucir.2019.06.002. Epub 2019 Sep 2. Neurocirugia (Astur : Engl Ed). 2020. PMID: 31488355 English, Spanish.
We report an uncommon case of osteoid osteoma recurring as an aggressive osteoblastoma of the spine. A 15-years-old male consulted in our department with long-term painful scoliosis. ...A percutaneous radiofrequency ablation was performed with complete resolution of the sy …
We report an uncommon case of osteoid osteoma recurring as an aggressive osteoblastoma of the spine. A 15-years-old male consulted in …
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
Most intolerance events (81 [70%] of 115 for ibrutinib; 15 [83%] of 18 for acalabrutinib) did not recur with zanubrutinib. Of the recurring events, seven (21%) of 34 ibrutinib intolerance events and two (67%) of three acalabrutinib intolerance events recurred
Most intolerance events (81 [70%] of 115 for ibrutinib; 15 [83%] of 18 for acalabrutinib) did not recur with zanubrutinib. Of the …
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature.
Maurelli M, Gisondi P, Colato C, Girolomoni G. Maurelli M, et al. Case Rep Dermatol. 2021 Jun 10;13(2):282-288. doi: 10.1159/000515999. eCollection 2021 May-Aug. Case Rep Dermatol. 2021. PMID: 34248533 Free PMC article.
Annually recurring erythema annulare centrifugum (AR-EAC) is a rare variant, characterized by typical annular plaques recurring in the same period of the year. ...Multiple annular plaques were located at the thighs in 4 patients and the neck in one patient. In 1 pat …
Annually recurring erythema annulare centrifugum (AR-EAC) is a rare variant, characterized by typical annular plaques recurring
56,773 results
You have reached the last available page of results. Please see the User Guide for more information.